1033245-12-3

Basic information

• Product Name: tert-butyl (2S,4S)-2-(aminomethyl)-4-fluoropyrrolidine-1-carboxylate
• Synonyms: tert-butyl (2S,4S)-2-(aminomethyl)-4-fluoropyrrolidine-1-carboxylate;(2S,4S)-tert-Butyl 2-(aminomethyl)-4-fluoropyrrolidine-1-carboxylate;Tert-Butyl (2S,4S)-2-(Aminomethyl)-4-Fluoro-1-Pyrrolidinecarboxylate(WX601104)
• CAS NO: 1033245-12-3
• Molecular Formula: C10H19FN2O2
• Molecular Weight: 218.27
• Mol File: 1033245-12-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 288.7±25.0 °C(Predicted)
• Appearance: /
• Density: 1.11±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 9.91±0.29(Predicted)
• CAS DataBase Reference: tert-butyl (2S,4S)-2-(aminomethyl)-4-fluoropyrrolidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (2S,4S)-2-(aminomethyl)-4-fluoropyrrolidine-1-carboxylate(1033245-12-3)
• EPA Substance Registry System: tert-butyl (2S,4S)-2-(aminomethyl)-4-fluoropyrrolidine-1-carboxylate(1033245-12-3)

Safety Data

• RIDADR: UN2811
• Hazardous Substances Data: 1033245-12-3(Hazardous Substances Data)

Usage

General Description

Tert-butyl (2S,4S)-2-(aminomethyl)-4-fluoropyrrolidine-1-carboxylate is a compound with the molecular formula C11H20FN2O2. It is a derivative of the amino acid proline and has a fluorine substitution at the 4th position of the pyrrolidine ring. This chemical is often used in medicinal and pharmaceutical research due to its potential as a building block for the synthesis of new drug compounds. The tert-butyl group provides stability and protection to the molecule, allowing for selective reactions and manipulation of its structure. The presence of the fluorine atom can also enhance the compound's interactions with biological targets, making it an attractive candidate for drug development.

Upstream product

• 317356-27-7 tert-butyl (2S,4S)-4-fluoro-2-(hydroxymethyl)pyrrolidine-1-carboxylate 
• 1138324-45-4 tert-butyl (2S,4R)-2-(azidomethyl)-4-fluoropyrrolidine-1-carboxylate 
• 203866-16-4 1-tert-butyl 2-methyl (2S,4S)-4-fluoropyrrolidine-1,2-dicarboxylate 
• 74844-91-0 1-tert-butyl 2-methyl (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate 
• 1138324-44-3 tert-butyl (2S,4R)-4-fluoro-2-(((methylsulfonyl)oxy)methyl)pyrrolidine-1-carboxylate 
• 1138324-48-7 (2S,4R)-tert-butyl 4-fluoro-2-(hydroxymethyl)pyrrolidine-1-carboxylate 
• 203866-18-6 methyl (2S,4R)-N-(tert-butyloxy)carbonyl-4-fluoropyrrolidine-2-carboxylate 
• 74844-91-0 (2S,4S)-N-tert-butoxycarbonyl-4-hydroxyproline methyl ester 

Downstream Products

• 1330075-80-3 C₃₃H₄₄F₂N₆O₅ 
• 1330075-79-0 C₃₂H₄₂F₂N₆O₅ 
• 1330075-78-9 C₃₁H₄₀F₂N₆O₅ 
• 1033244-26-6 C₂₂H₂₅F₃N₆O 
• 1033244-28-8 C₂₁H₂₃F₃N₆O 
• 1033244-29-9 C₂₂H₂₆F₂N₆OS 
• 1033244-32-4 C₂₁H₂₄F₂N₆OS 
• 1330075-48-3 C₂₃H₂₆F₂N₆O 
• 1330075-47-2 C₂₂H₂₄F₂N₆O 

Relevant articles and documents

BENZIMIDAZOLE-LINKED INDOLE COMPOUND ACTING AS NOVEL DIVALENT IAP ANTAGONIST

The present invention discloses a benzimidazole-linked indole compound acting as novel divalent IAP antagonist, specifically disclosing the compound shown in fomulas (I) or a pharmaceutically acceptable salt thereof.

Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 2: Improvement of potency in vitro and in vivo

We have increased the potency of imidazo[1,2-b]pyridazine derivatives as IKKβ inhibitors with two strategies. One is to enhance the activity in cell-based assay by adjusting the polarity of molecules to improve permeability. Another is to increase the affinity for IKKβ by the introduction of additional substituents based on the hypothesis derived from an interaction model study. These improved compounds showed inhibitory activity of TNFα production in mice.